TABLE 2.
Susceptibilities of bacterial strains to selected aminoglycosides
| Strain (plasmid) | MIC (μg/ml)a
|
|||||
|---|---|---|---|---|---|---|
| KAN | TOB | NET | GEN | AMI | ISE | |
| E. cloacae | ||||||
| ECl562(pLMM562) | 64 | 16 | 8 | 2 | 2 | 0.5 |
| ECl563(pLMM563) | 128 | 16 | 16 | 4 | 4 | 1 |
| C. freundii CFr564 (pLMM564) | 32 | 8 | 4 | 2 | 2 | 0.5 |
| P. aeruginosa PAO28 (pSCH884) | >256 | >256 | >256 | 128 | 4 | 4 |
| E. coli | ||||||
| HB101 | 1 | 0.25 | 0.12 | 0.25 | 0.5 | 0.25 |
| HB101(pLMM562) | 64 | 4 | 2 | 1 | 1 | 0.25 |
| HB101(pLMM563) | 128 | 8 | 8 | 2 | 1 | 0.5 |
| HB101(pLMM564) | 32 | 4 | 2 | 2 | 1 | 0.25 |
| DH5α(pAZ505) | 128 | 128 | 64 | 1 | 32 | 8 |
a
KAN, kanamycin; TOB, tobramycin; NET, netilmicin; GEN, gentamicin; AMI, amikacin; ISE, isepamicin.